ICAN Challenges FDA’s Move to Weaken its Already Paltry Clinical Trial Requirements for Vaccine Approval
ICAN Uncovers a Potential Next-Level Threat: “Inhalable” Self-Spreading Vaccines that Spread Like a Virus
